Odesa

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis2 trials

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Sanofi2 trials

Closed trials

• Completed

  Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)

  NCT04410978· Phase 3· Sanofi· Source

• Completed

  Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis

  NCT03996291· Phase 2· Sanofi· Source